NUS Medicine and NOVI Health sign MOU to explore research and development
Published: 15 Sep 2026
From left to right: Adj Assoc Prof Kyle Tan, NUS Saw Swee Hock School of Public Health, and co-founder of NOVI Health; Adj Assoc Prof Sue-Anne Toh, NUS Medicine, and Chief Executive Officer and co-founder of NOVI Health; Mr George Loh, Associate Vice President (Strategic Partnership) at NUS ; Prof Chong Yap Seng, Dean of NUS Medicine.
The Yong Loo Lin School of Medicine, National University of Singapore, has signed a Memorandum of Understanding (MOU) with NOVI Health to explore opportunities for collaboration in research and development.
The MOU provides a framework for both parties to explore potential joint research projects, as well as the exchange of scientific and technical information, data and materials. It also creates opportunities to identify and pursue future projects of mutual interest in healthspan and longevity.
The collaboration builds on a longstanding relationship between NOVI Health’s founders and NUS Medicine, which has been shaped by their professional and academic journeys across clinical medicine, preventive health, research, medical education and population health.
Through the MOU, NUS Medicine and NOVI Health will explore opportunities to deepen their collaboration, with potential future projects to be developed through separate agreements.
